New Guidelines Strengthen Good Distribution Practice (GDP)

This new white paper is designed to provide an overview of the recently introduced EU Guidelines on the Good Distribution Practice (GDP) of Medicinal Products for Human Use and the significant new demands placed on the manufacturers and distributors of pharmaceutical products. Partly driven by the need to prevent counterfeit and falsified medicines from entering the legitimate supply chain.

5 key benefits of downloading this white paper:

• Understand the new GDP Guidelines as covered by EU Directives/Regulations and Guidelines and the implications of these new guidelines on the pharmaceutical industry.
• Provide a better understanding to the new demands placed on manufactures, distributors of pharmaceutical raw materials and finished products.
• Review GMP/GDP supply chain integrity and the growing concern of counterfeit pharmaceutical products.
• Explore the importance of training all those involved in the manufacturing process and distribution process and complying with regulations.
• Understand the GDP responsibilities for drivers of a vehicle used to transport medicinal products and the specific online training available for drivers.

Who should read this white paper?

All those involved in distribution and transporting pharmaceutical products :

Distribution managers, distribution supervisors, distribution directors, logistic managers, logistic directors, logistic supervisors, drivers.

Have Your Say Rate this feature and give us your feedback in the comments section below